Trial record 1 of 1 for: radiotherapy ARTFORCE | Head and Neck Cancer | Groningen, Netherlands

Previous Study | Return to List | Next Study

Adaptive Radiation Treatment for Head and Neck Cancer (ARTFORCE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT01504815

Recruitment Status : Active, not recruiting

First Posted : January 5, 2012

Last Update Posted : July 6, 2023

View this study on the modernized ClinicalTrials.gov

Sponsor:

Collaborators:

Karolinska Institutet

Maastricht Radiation Oncology

Institut Catala de Salut

The Christie NHS Foundation Trust

Gustave Roussy, Cancer Campus, Grand Paris

UMC Utrecht

European Union

Information provided by (Responsible Party):

The Netherlands Cancer Institute

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Active, not recruiting
Estimated Primary Completion Date :	November 2023
Estimated Study Completion Date :	September 2025

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Heukelom J, Hamming O, Bartelink H, Hoebers F, Giralt J, Herlestam T, Verheij M, van den Brekel M, Vogel W, Slevin N, Deutsch E, Sonke JJ, Lambin P, Rasch C. Adaptive and innovative Radiation Treatment FOR improving Cancer treatment outcomE (ARTFORCE); a randomized controlled phase II trial for individualized treatment of head and neck cancer. BMC Cancer. 2013 Feb 22;13:84. doi: 10.1186/1471-2407-13-84.

To Top